Resilience Biosciences
Resilience Biosciences Inc. is a clinical-stage biopharmaceutical start-up engaged in assessing the safety and clinical efficacy of a lead non-prescription Natural Health Products (NHPs) to facilitate successful withdrawal from chronic opioid dependence using rigorous, well-designed clinical studies. Their strategy of identifying key bioactive molecules within traditional Asian medicines is coupled with complementary research focusing on the development of novel, non-opioid medications for pain and other indications. Accordingly, the company is addressing two of the most significant unmet needs in 21st century medicine. This approach promises better patient outcomes and more rapid introduction into practice to address key aspects of the current overdose crisis.
